Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1920 1
1921 1
1931 1
1945 1
1946 1
1947 1
1948 2
1949 2
1950 2
1951 4
1952 4
1953 7
1954 5
1955 3
1956 4
1957 7
1958 2
1959 3
1960 2
1961 2
1963 1
1964 1
1965 1
1966 3
1968 2
1969 2
1971 4
1972 3
1974 3
1976 2
1977 6
1978 5
1979 2
1980 2
1981 4
1982 10
1983 2
1984 8
1985 15
1986 10
1987 9
1988 5
1989 8
1990 5
1991 9
1992 11
1993 7
1994 7
1995 6
1996 8
1997 6
1998 5
1999 3
2000 9
2001 10
2002 6
2003 12
2004 8
2005 6
2006 12
2007 11
2008 12
2009 7
2010 20
2011 5
2012 13
2013 11
2014 8
2015 7
2016 11
2017 20
2018 14
2019 11
2020 18
2021 38
2022 41
2023 39
2024 33
2025 35
2026 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

612 results

Results by year

Filters applied: . Clear all
Page 1
Polyarteritis Nodosa: Old Disease, New Etiologies.
Wolff L, Horisberger A, Moi L, Karampetsou MP, Comte D. Wolff L, et al. Int J Mol Sci. 2023 Nov 23;24(23):16668. doi: 10.3390/ijms242316668. Int J Mol Sci. 2023. PMID: 38068989 Free PMC article. Review.
Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial.
Olthuis SGH, Pirson FAV, Pinckaers FME, Hinsenveld WH, Nieboer D, Ceulemans A, Knapen RRMM, Robbe MMQ, Berkhemer OA, van Walderveen MAA, Lycklama À Nijeholt GJ, Uyttenboogaart M, Schonewille WJ, van der Sluijs PM, Wolff L, van Voorst H, Postma AA, Roosendaal SD, van der Hoorn A, Emmer BJ, Krietemeijer MGM, van Doormaal PJ, Roozenbeek B, Goldhoorn RB, Staals J, de Ridder IR, van der Leij C, Coutinho JM, van der Worp HB, Lo RTH, Bokkers RPH, van Dijk EI, Boogaarts HD, Wermer MJH, van Es ACGM, van Tuijl JH, Kortman HGJ, Gons RAR, Yo LSF, Vos JA, de Laat KF, van Dijk LC, van den Wijngaard IR, Hofmeijer J, Martens JM, Brouwers PJAM, Bulut T, Remmers MJM, de Jong TEAM, den Hertog HM, van Hasselt BAAM, Rozeman AD, Elgersma OEH, van der Veen B, Sudiono DR, Lingsma HF, Roos YBWEM, Majoie CBLM, van der Lugt A, Dippel DWJ, van Zwam WH, van Oostenbrugge RJ; MR CLEAN-LATE investigators. Olthuis SGH, et al. Among authors: wolff l. Lancet. 2023 Apr 22;401(10385):1371-1380. doi: 10.1016/S0140-6736(23)00575-5. Epub 2023 Mar 29. Lancet. 2023. PMID: 37003289 Clinical Trial.
VEXAS syndrome: a Swiss national retrospective cohort study.
Wolff L, Caratsch L, Lötscher F, Seitz L, Seitz P, Coattrenec Y, Seebach J, Vilinovszki O, Balabanov S, Nilsson J, Canbek A, Clottu A, Bruecker R, Efthymiou A, Regli D, Chrysoula M, Amstad A, Bonadies N, Blum S, Chitic M, Schreiber C, Comte D. Wolff L, et al. Swiss Med Wkly. 2024 Mar 14;155:3879. doi: 10.57187/s.3879. Swiss Med Wkly. 2024. PMID: 40132164 Free article.
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI).
Bowman SJ, Seror R, Porcher R, Arends S, de Wolff L, Verstappen G, Devauchelle-Pensec V, Jousse-Joulin S, Baldini C, Bombardieri M, Pontarini E, Hueber W, Marvel J, Goswami P, Cornec D, Fisher BA, Nayar S, Barone F, Ng WF, Gottenberg JE, Bootsma H, Dörner T, Pincemin M, Bouillot C, Hammitt KM, Wahren-Herlenius M, van Roon J, Nocturne G, Laigle L, Moingeon P, Christodoulou A, Sreih AG, van Maurik A, Chen WH, Wisniacki N, Piatrova A, Jonsson R, Gergely P, Mariette X. Bowman SJ, et al. Among authors: de wolff l. Ann Rheum Dis. 2025 Jul;84(7):1068-1089. doi: 10.1016/j.ard.2025.05.004. Epub 2025 Jun 17. Ann Rheum Dis. 2025. PMID: 40527714 Free article. Review.
Letters.
Bandt C, Pihlstrom BL, Wolff L, Bakdash B. Bandt C, et al. Among authors: wolff l. J Am Dent Assoc. 2018 Feb;149(2):86. doi: 10.1016/j.adaj.2017.12.022. J Am Dent Assoc. 2018. PMID: 29389344 No abstract available.
A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke.
LeCouffe NE, Kappelhof M, Treurniet KM, Rinkel LA, Bruggeman AE, Berkhemer OA, Wolff L, van Voorst H, Tolhuisen ML, Dippel DWJ, van der Lugt A, van Es ACGM, Boiten J, Lycklama À Nijeholt GJ, Keizer K, Gons RAR, Yo LSF, van Oostenbrugge RJ, van Zwam WH, Roozenbeek B, van der Worp HB, Lo RTH, van den Wijngaard IR, de Ridder IR, Costalat V, Arquizan C, Lemmens R, Demeestere J, Hofmeijer J, Martens JM, Schonewille WJ, Vos JA, Uyttenboogaart M, Bokkers RPH, van Tuijl JH, Kortman H, Schreuder FHBM, Boogaarts HD, de Laat KF, van Dijk LC, den Hertog HM, van Hasselt BAAM, Brouwers PJAM, Bulut T, Remmers MJM, van Norden A, Imani F, Rozeman AD, Elgersma OEH, Desfontaines P, Brisbois D, Samson Y, Clarençon F, Krietemeijer GM, Postma AA, van Doormaal PJ, van den Berg R, van der Hoorn A, Beenen LFM, Nieboer D, Lingsma HF, Emmer BJ, Coutinho JM, Majoie CBLM, Roos YBWEM; MR CLEAN–NO IV Investigators. LeCouffe NE, et al. Among authors: wolff l. N Engl J Med. 2021 Nov 11;385(20):1833-1844. doi: 10.1056/NEJMoa2107727. N Engl J Med. 2021. PMID: 34758251 Clinical Trial.
Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell-Targeted Therapy in the Trial of Anti-B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS).
Pontarini E, Sciacca E, Chowdhury F, Grigoriadou S, Rivellese F, Murray-Brown WJ, Lucchesi D, Fossati-Jimack L, Nerviani A, Jaworska E, Ghirardi GM, Giacomassi C, Emery P, Ng WF, Sutcliffe N, Everett C, Fernandez C, Tappuni A, Seror R, Mariette X, Porcher R, Cavallaro G, Pulvirenti A, Verstappen GM, de Wolff L, Arends S, Bootsma H, Lewis MJ, Pitzalis C, Bowman SJ, Bombardieri M; Trial for Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome Study Research Group. Pontarini E, et al. Among authors: de wolff l. Arthritis Rheumatol. 2024 May;76(5):763-776. doi: 10.1002/art.42772. Epub 2024 Feb 15. Arthritis Rheumatol. 2024. PMID: 38073013 Clinical Trial.
612 results